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        Introduction 
  Fusion of cells to form multinucleated syncytia is fundamental 
to the development and maintenance of diverse tissues in eu-
karyotic organisms. The incorporation of additional nuclei in 
mammalian skeletal muscle cells, multinucleated giant cells, 
osteoclasts, and trophoblast tissue serves to augment tissue size 
and function (  Potgens et al., 2004  ;   Chen and Olson, 2005  ;   Quinn 
and Gillespie, 2005  ). In skeletal muscle, fusion results in the 
generation of elongated fi  bers, with nuclei oriented longitudinally, 
providing instruction for contractile protein production within 
specifi  c domains along the fi  ber (  Pavlath et al., 1989  ;  Horsley 
and Pavlath, 2004  ). In contrast, multinucleated cells derived from 
macrophages have globular forms, with centrally located nu-
clear clusters, a morphology thought to serve important roles in 
foreign body removal (  Vignery, 2005  ). How syncytial cells incor-
porate nuclei in a controlled fashion and attain particular morph-
ologies enabling unique functions remains poorly understood. 
  Studies in   Drosophila   and   Caenorhabditis elegans   have 
identifi  ed three phases of cell fusion: recognition and adhesion, 
cytoskeletal rearrangement, and membrane merger (  Chen et al., 
2007  ). Impeding the fi  rst phase of fusion by eliminating or block-
ing protein function has led to the identifi  cation of an array of 
surface proteins in myoblasts and in macrophages responsible 
for cell-specifi  c adhesion and recognition of appropriate fusion 
partners (  Greve and Gottlieb, 1982  ;   Rosen et al., 1992  ;   Charlton 
et al., 2000  ;   Gorza and Vitadello, 2000  ;   Schwander et al., 2003  ; 
  Vignery, 2005  ;   Jansen and Pavlath, 2006  ). 
  In the later stages of fusion, cytoskeletal rearrangement is 
responsible for architectural reorganization and coordinates the 
formation of functional syncytia. Screening of   Drosophila   mu-
tants has implicated guanine-nucleotide exchange factors (GEFs) 
in the development of skeletal muscle by demonstrating failure 
of fusion of muscle cells in embryos that carry mutations in the 
GEFs   Myoblast city   (  Erickson et al., 1997  ) and   Loner   ( Chen 
et al., 2003  ). These GEFs are components of two separate signal 
transduction pathways, both predicted to converge on the GTPase 
Rac (  Chen et al., 2007  ). Likewise in zebrafi  sh, components of the 
Dock1-Crk-Rac pathway (  Moore et al., 2007  ), and the Kirre-Rst 
pathway (  Srinivas et al., 2007  ), the role of which in unclear in 
mammals, have been shown to function in fast-twitch muscle 
fi  ber formation. The roles of both Brag2 and Dock180 have yet 
to be studied in mammalian cell  –  cell fusion. 
  The mammalian homologue of   Myoblast city,   Dock180  is 
a Src-homology 3 (SH3) protein that interacts with the adaptor 
protein Crk, and activates Rac1 by direct binding (  Hasegawa 
C
ell  –  cell fusion is critical to the normal development 
of certain tissues, yet the nature and degree of 
conservation of the underlying molecular compo-
nents remains largely unknown. Here we show that 
the two guanine-nucleotide exchange factors Brag2 and 
Dock180 have evolutionarily conserved functions in the 
fusion of mammalian myoblasts. Their effects on muscle 
cell formation are distinct and are a result of the activation 
of the GTPases ARF6 and Rac, respectively. Inhibition of 
ARF6 activity results in a lack of physical association be-
tween paxillin and       1  -integrin, and disruption of paxillin 
transport to sites of focal adhesion. We show that fusion 
machinery is conserved among distinct cell types because 
Dock180 deﬁ   ciency prevented fusion of macrophages 
and the formation of multinucleated giant cells. Our re-
sults are the ﬁ  rst to demonstrate a role for a single protein 
in the fusion of two different cell types, and provide novel 
mechanistic insight into the function of GEFs in the mor-
phological maturation of multinucleated cells.
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irrespective of fusion. This paper is the fi  rst to document a shared 
component of fusion machinery among different fusogenic cell 
types, implying that cell fusion has common evolutionary ancestry. 
  Results 
  Brag2 and Dock180 expression and 
silencing in myoblasts 
  We analyzed the mRNA levels of Brag2 and Dock180 in C2C12 
myoblasts during proliferation (growth media [GM]) and after 
d 4 in differentiation media (DM). Semi-quantitative (  Fig. 1 A  ) 
and real-time RT-PCR (  Fig. 1 C  ) indicate a fourfold induction 
of Brag2 levels during differentiation, while there is no signifi  -
cant change in Dock180 mRNA levels.    
  Stable cell lines defi  cient in Brag2 and Dock180 were cre-
ated using restriction enzyme  –  generated siRNAs (REGS) (  Sen 
et al., 2004  ). Several short hairpin RNA (shRNA) candidates 
were retrovirally delivered to myoblasts, and mRNA expression 
levels were verifi  ed by PCR after puromycin selection.   Fig. 1 B   
shows knockdown of Brag2 and Dock180 using the shRNAs 
that were chosen for this study. Both Brag2Si and Dock180Si 
cell lines exhibited   >  70% reduction in expression when com-
pared with cells treated with control shRNA (CntSi) (  Fig. 1 D  ). 
A double knockdown (DKD) cell line was generated by infect-
ing Brag2Si cells with Dock180Si retrovirus (  Fig. 1, B and D  ). 
The Cnt2Si cell line underwent equal rounds of infection with con-
trol shRNAs as the DKD line. Protein levels of Brag2 and Dock180 
at DM d 4 were verifi  ed by Western analysis (Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200707191/DC1). 
In total, fi  ve myoblast cell lines were generated, two control 
lines expressing control shRNAs, and three cell lines defi  cient in 
the expression levels of Brag2, Dock180, or both genes. 
  Brag2- and Dock180-deﬁ  cient muscle cells 
share a similar decrease in fusion index but 
have distinct myotube morphologies 
 Mutation of Brag2 and Dock180 homologues leads to aberrant em-
bryonic muscle development in   Drosophila   ( Erickson  et  al.,  1997 ; 
et al., 1996  ;   Kiyokawa et al., 1998  ). Biochemical characteriza-
tion of Dock180 placed it in the CDM family of GEF proteins 
(  Cote and Vuori, 2002  ), which have varying, context-dependent 
roles ranging from membrane ruffl  ing and cell migration to phago-
cytosis (  Cheresh et al., 1999  ;   Albert et al., 2000  ;   Gumienny 
et al., 2001  ). The mammalian homologue of Loner is Brag2/
GEP  100  , a GEF of ADP ribosylation factor 6 (ARF6). In addi-
tion to the Sec7 domain common to other ARF family GEFs, 
Brag2 contains a nuclear localization signal and an IQ motif 
(  Someya et al., 2001  ). Concordant with the known functions of 
ARF6 (  D  ’  Souza-Schorey and Chavrier, 2006  ), the roles of Brag2 
in mammalian nonmuscle cells involve the regulation of cell 
adhesion by controlling    1-integrin  endocytosis  and  E-cadherin 
redistribution (  Dunphy et al., 2006  ;   Hiroi et al., 2006  ). 
  Evidence suggests that Loner activation of ARF6 is re-
sponsible for transport of Rac to sites of cell fusion in   Drosophila  
(  Chen et al., 2003  ). Transport of Rac in vesicles to the plasma 
membrane has also been observed in mammalian cells, and found 
to be partly dependent on chemically activated ARF6 (  Boshans 
et al., 2000  ). Regulation of Rac activity is involved in differen-
tiation of myoblasts (  Heller et al., 2001  ;   Samson et al., 2007  ), 
cell shape determination, and tissue invasion by macrophages 
and neutrophils (  Pestonjamasp et al., 2006  ;   Wheeler et al., 2006  ). 
Studies that have attempted to characterize the role of Rac in 
myoblast differentiation and cell cycle withdrawal have arrived 
at contradicting conclusions (  Meriane et al., 2000, 2002  ) partly 
because of the wide array of cellular processes infl  uenced by 
Rho/Rac GTPases (  Hall, 2005  ). 
  We have used RNA interference in cultured mammalian 
cells to study how Brag2 and Dock180 control the formation of 
multinucleated cells. We investigated two different cell types, 
myoblasts and macrophages, which fuse under different condi-
tions, and have disparate morphologies (  Helming and Gordon, 
2007  ). Our results suggest that these two GEFs are required for 
the formation of large multinucleated structures characteristic 
of each cell type. However, we provide evidence for divergent 
downstream mechanisms each responsible for distinct components 
of cellular morphology as well as the initiation of differentiation 
  Figure 1.       Expression and knockdown of 
Brag2 and Dock180 in C2C12 myoblasts.   
(A) Brag2 (1,100 bp) and Dock180 (2,485 bp) 
expression during growth (GM) and differ-
entiation (DM) as shown by RT-PCR. GAPDH 
(250 bp). (B) Total RNA from cell lines Brag2Si, 
Dock180Si, and DKD, was harvested after 
d 4 in DM, and tested for Brag2 and Dock180 
expression by RT-PCR. (C) Quantitative PCR 
analysis of Brag2 (dark gray) and Dock180 
(light gray) expression in GM and d 4 DM. 
Values are normalized to the expression in 
CntSi cells (white). (D) Quantitative PCR analy-
sis of Brag2 and Dock180 expression from 
Brag2Si, Dock180Si, and DKD cells. Values 
are normalized to the expression of CntSi and 
Cnt2Si cells. Error bars indicate the mean   ±   SE 
of three independent determinations.     1007 MOLECULAR BASIS OF CELL–CELL FUSION   •   PAJCINI ET AL.
http://www.jcb.org/cgi/content/full/jcb.200707191/DC1). Next, we 
analyzed cell cycle progression using BrdU incorporation and 
found no difference among the cell lines (Fig. S2 B). Thus, 
Brag2 and Dock180 are dispensable for myoblast morphology 
and proliferation. In addition, retroviral infection and selection 
did not overtly affect the growth properties of these cells. 
  Chen et al., 2003  ). This has been attributed to defects in cell 
fusion; however, the impact of Brag2 and Dock180 defi  ciency in 
established myoblasts has not been investigated. We compared 
the fi  ve cell lines actively proliferating to each other and to un-
infected myoblasts for morphological defects, and found com-
parable myoblast morphology among all (Fig. S2 A, available at 
  Figure 2.       Brag2- and Dock180-deﬁ  cient cells have similar fusion index but disparate myotube morphologies.   (A) Immunoﬂ  uorescence images from each 
cell line, after d 6 in DM. Cells were labeled with primary antibody to MHC and secondary Alexa 488 (green) and Hoechst 33258 (blue). Bar, 50   μ  m. 
(B) Total fusion index analysis representing the number of nuclei in multinucleated myotubes divided by total number of nuclei in a ﬁ  eld, with a myotube 
deﬁ  ned by at least three nuclei. A minimum of 4,000 nuclei were counted from random ﬁ  elds of each line at d 6 in DM. P value was determined with a 
  t   test, in which CntSi served as control for Brag2Si and Dock180Si cells and Cnt2Si served as control for DKD (*, P   <   0.00001). (C) Fusion index analysis 
indicating the formation of di-, tri-, tetra-, or penta+ multinucleated myotubes after d 6 in DM. All error bars indicate the mean   ±   SE of at least four inde-
pendent determinations (*, P   <   0.00001). (D) Representative immunoﬂ  uorescence images of d 6 DM ﬁ  elds used in the fusion index analysis. Bar, 200   μ  m. 
(E)     -gal complementation assay of fusion of Brag2Si, Dock180Si, and C2C12 control cells containing equal populations of     - and     -fragments over the 
course of 5 d in DM. Background luminescence determined by C2C12 control cells containing     - and     -fragments of     -gal seeded under proliferation 
conditions. (  n   = 3).     JCB • VOLUME 180 • NUMBER 5 • 2008  1008
strongly impeded in each of the knockdowns. These results in-
dicate that Brag2 and Dock180 are essential for the forma-
tion of   mature myotubes, but that each has a distinct effect on 
cell morphology. 
  To analyze whether fusion defects observed in culture are 
retained in vivo, we injected GFP 
+   cells from each of the cell 
lines into the tibialis anterior (TA) of CB17/SCID mice. 1 wk 
after injection we analyzed cross sections of the TA from each 
of the injected animals. Control myoblasts fuse regularly at 
the site of injection, as can be seen by the presence of GFP 
+ -
laminin – bound  myofi  bers (Fig. S4, available at http://www.jcb
.org/cgi/content/full/jcb.200707191/DC1). However, both Brag2- 
and Dock180-defi  cient cells fail to form GFP 
+   myofi  bers and 
lead to the disruption of the existing musculature as indicated 
by the dearth of laminin-bound structures at the injection site. 
Thus, GEFs are necessary for the fusion of myoblasts to exist-
ing myotubes, a function distinct from their known role in the 
formation of developing muscle in   Drosophila   and zebrafi  sh 
(  Chen et al., 2003  ;   Moore et al., 2007  ). 
      -Galactosidase complementation reveals 
early and late fusion defects 
  The fusion index as determined by blind counting trials of ran-
dom image fi  elds has disadvantages such as limited sample 
size. It is also tedious, potentially contributing to human error. 
The fusion index analysis at d 6 DM attributed the fusion defect 
we observed in Brag2Si and Dock180Si cells primarily to myo-
tube growth. To verify this result by a quantitative biochemical 
approach, we took advantage of    -galactosidase  (  -gal)  enzy-
matic complementation, which has been previously used in 
mammalian cells to examine cell fusion (  Mohler and Blau, 
1996  ) and protein  –  protein interactions (  Rossi et al., 2000  ; 
  Wehrman et al., 2002  ). Brag2Si, Dock180Si, and C2C12 cells 
were split in two sub-populations, each of which was infected 
with retroviral vectors encoding one of the two complement-
ing     -gal fragments (  Wehrman et al., 2005  ). The infected sub-
populations, one carrying the     -peptide-GFP and the other 
carrying the     -deletion-GFP were expanded separately and 
FACS sorted to equilibrate the levels of expression of each frag-
ment. The two sub-populations were mixed in equal proportions 
before seeding in 96-well plates (  n   = 3). Fusion, assayed as a 
bioluminescence reading every 24 h for 5 d, demonstrated a 
  decrease in enzymatic activity in the Brag2Si and Dock180Si 
cells, confi  rming the fusion index results. Similar to the fusion 
index analysis, the two knockdown cell lines exhibit very simi-
lar levels of enzyme activity over the course of the experiment. 
However,     -gal analysis revealed that the kinetics of fusion 
differed at two separate periods: early stages between d 1 and 3 
in DM and later stages between d 4 and 5 in DM (  Fig. 2 E  ). 
During these time points Brag2- and Dock180-defi  cient cells 
show smaller factors of luminescence increase than controls 
(C2C12 = 1.4248, Brag2Si = 1.3585, Dock180Si = 1.3581), 
which indicates that Brag2Si and Dock180Si myotube matura-
tion does not progress normally after early myotube formation. 
However, the     -gal fusion analysis also indicates an additional 
fusion defect early in the course of differentiation for the two 
knockdown cell lines. 
  To determine if Brag2 and Dock180 play roles in mam-
malian myoblast fusion, 5.0   ×   10 
5   cells were seeded in DM on 
collagen-coated plates. Media was changed daily, and on d 3, 
ArabinoseC (  Cozzarelli, 1977  ) was added in order to remove 
proliferating cells and improve the visibility of myotube mor-
phology. In the CntSi and Cnt2Si cell lines the majority of 
myoblasts had fused by d 3 in DM, and these myotubes in-
creased in size over the next days. After d 6 in DM, cells were 
analyzed by immunofl  uorescence for expression of myosin 
heavy chain (MHC). Uncharacteristic myotube morphol-
ogy was apparent when comparing myotubes from Brag2Si, 
Dock180Si, and DKD cells to the controls (  Fig. 2 A  ).    Control 
cells formed robust myotubes that elongated past 800   μ  m 
in length with a diameter of over 30   μ  m, evenly distributed 
  nuclei, striations, and contractility. In contrast, the majority 
Brag2Si cells that differentiated failed to form myotubes con-
taining three or more nuclei, as indicated by the presence of 
a majority of single or double nucleated cells. When larger 
myotubes did form by the Brag2Si cells (  Fig. 2, A and D  ) 
they produced   “  stubby  ”   syncytia, termed bragballs, in which 
elongation failed to occur and nuclei remained centrally clus-
tered. A majority of Dock180Si cells also failed to fuse. How-
ever, in direct contrast to Brag2Si, Dock180Si myotubes 
elongated appropriately (  Fig. 2,   A and D), but formed struc-
tures comparatively destitute of nuclei that resemble atrophic 
myotubes (  Stevenson et al., 2005  ). The most drastic fusion 
  defect was observed in the DKD cell line. These cells only 
fused to form simple structures (  Fig. 2 A  ) and exhibited a dis-
cernible decrease in the proportion of MHC-positive cells 
(  Fig. 2 D  ). The rare multinucleated cells strongly resembled 
bragballs, but had an even more pronounced ball-like mor-
phology lacking even the most rudimentary elongated struc-
tures expected of myotubes. 
  To quantify the fusion defects, 3.7   ×   10 
6   cells were seeded 
in triplicate for fusion index analysis. After d 6 in DM, the fu-
sion index was determined by counting the numbers of nuclei 
within MHC 
+   cells as a percentage of total nuclei present in 
each of the randomly captured fi  elds (  Fig. 2 D  ). Despite striking 
morphological differences, Brag2Si and Dock180Si cells share 
a similar fusion index of just over 20%, whereas the DKD fu-
sion index is slightly lower at 15% (  Fig. 2 B  ). This represented 
a decrease in fusion index of 30 and 35%, respectively, com-
pared with control cells. The aberrant morphology observed in 
the knockdown cell lines suggested that the common fusion in-
dex analysis, which assigns the label of   “  myotube  ”   to any cell 
containing more than three nuclei, understates the fusion de-
fect occurring in the Brag2- and Dock180-defi  cient cells. 
  Although a three-nucleated cell indicates the occurrence of 
  fusion, it is not representative of a functional mammalian myo-
tube, which is capable of incorporating hundreds of nuclei 
per myofi  ber in culture and in vivo. Thus, we quantifi  ed the 
  occurrence of a range of myotube sizes from the di-nucleated to 
fi  ve or more (penta+) nucleated structures. (  Fig. 2 C  ). These 
data clearly show that there is no disparity among the formation 
of di-, tri-, or even tetra-nucleated structures, but that the differ-
ence observed in the total fusion index can be accredited to 
the formation of large, penta+ nucleated myotubes, which is 1009 MOLECULAR BASIS OF CELL–CELL FUSION   •   PAJCINI ET AL.
late skeletal muscle differentiation is the expression of struc-
tural proteins such as MHC. We analyzed all cell lines for the 
expression of these myogenic factors. Cells were seeded sparsely 
in order to avoid cell  –  cell contact, and maintained in DM for 72 h, 
after which they were double stained for myogenin and MHC. 
Control cells showed the highest levels of myogenin expression 
at 54   ±   5.3%, whereas in Brag2Si (18   ±   2.9%) and Dock180 (23   ±   
3.2%) fewer differentiation events occurred (  Fig. 3   D). DKD 
cells further confi  rmed the BrdU trend by exhibiting the lowest 
levels of myogenin expression in only 15   ±   3.5% total nuclei. 
Representative images are displayed in   Fig. 3   C. MHC ex-
pression followed a similar pattern to myogenin, with control 
cells expressing the highest levels of MHC. The percentage of 
differentiated cells likely represents an underestimate of the pro-
portion of cells originally capable of differentiation because cells 
that failed to differentiate continue to cycle. These data indicate 
that Brag2 and Dock180 are required in myoblasts for effi  cient 
cell cycle exit and induction of the differentiation program, and 
segregates these functions from fusion because these experi-
ments were performed at low density. It is possible that the early 
fusion defect observed in the     -gal complementation assay re-
fl  ects a failure to induce the fusion-related portion of the differ-
entiation program in Brag2- and Dock180-defi  cient cells, but 
these experiments suggest additional roles for these molecules 
in muscle differentiation. 
  Brag2 and Dock180 lead to deﬁ  cient 
ARF6 and Rac1 activation, respectively, 
during myoblast fusion 
  Brag2 and Dock180 are responsible for the activation of 
GTPases ARF6 and Rac1, respectively (  Kiyokawa et al., 1998  ; 
  Delayed cell cycle withdrawal and impaired 
differentiation contribute to the early 
fusion defect in Brag2Si and 
Dock180Si cells 
  Fusing cells were visualized by time-lapse microscopy over the 
course of 2  –  4 d in DM. When compared with the fusion of the 
CntSi cells (Video 1), the formation of the Brag2Si bragballs 
(Video 2) and thin Dock180Si myotubes (Video 3) is evident. 
However, during the fi  rst 24  –  36 h of image capture, large num-
bers of Dock180Si, Brag2Si, and especially DKD cells (Video 4) 
die and detach, indicative of aberrant proliferation in the presence 
of ArabinoseC (Videos are available at http://www.jcb.org/cgi/
content/full/jcb.200707191/DC1). Furthermore, Brag2Si and 
Dock180Si cells injected into the TA showed tremendous prolif-
eration, as can be seen by the large numbers of GFP 
+   cells at the 
site of injection when compared with the control cells (Fig. S4). 
  BrdU labeling experiments were designed to determine the 
extent of differentiation defi  ciency in the knockdowns. Myoblasts 
were seeded sparsely, 1.0   ×   10 
4   cells per 6-cm plate (  n   = 9). 
After 24 h in DM, cells were labeled with BrdU for 6 h (  Zhang 
et al., 2007  ). It is clearly evident, as shown in   Fig. 3 A  , that the 
number of cells per fi  eld was higher in the DKD cells, indicat-
ing proliferation despite DM conditions. BrdU analysis con-
fi  rms this observation because 67   ±   3.9% of DKD cells are 
BrdU positive when compared with the 35   ±   4.6% from Cnt2Si, 
24 h after serum withdrawal. This phenotype was shared by 
Brag2Si cells (63   ±   6.4%), and to a lesser extent by the Dock180Si 
cells (52   ±   3.5%) (  Fig. 3 B  ).    
  Cell cycle withdrawal, an early step in differentiation, is 
followed by the induction of myogenin, signifying terminal dif-
ferentiation (  Sabourin and Rudnicki, 2000  ). Further evidence of 
  Figure 3.       Delayed cell cycle withdrawal and differentiation in Brag2- and Dock180-deﬁ  cient myoblasts.   (A) Merged laser-scanning confocal image of repre-
sentative ﬁ  elds of Cnt2Si and DKD myoblasts after 24 h in DM, labeled for BrdU (green) and with To-Pro (blue). BrdU 
+   nuclei are colored in teal in the merged 
image. Bar, 100   μ  m. (B) BrdU incorporation for each stable cell line after 24 h in DM and a 6-h BrdU incubation. (*P   <   0.001). (C) Immunoﬂ  uorescence of 
representative image ﬁ  elds of Cnt2Si and DKD myoblasts after 72 h in DM, labeled for myogenin (red), MHC (green), and with Hoechst 33258 (blue). Bar, 
50   μ  m. (D) Differentiation as measured by myogenin (*, P   <   0.0006) and MHC (**, P   <   0.003; ***, P   <   0.03) expression for each stable cell line after 72 h 
in DM. In all cases, error bars indicate the mean   ±   SE of three independent determinations, in which a minimum of 1,000 nuclei were counted per trial.     JCB • VOLUME 180 • NUMBER 5 • 2008  1010
M-cadherin were unaffected in either knockdown, Dock180 
 defi  ciency resulted in a twofold increase in    1-integrin  ex-
pression (  Fig. 5  ).    We also analyzed the localization and protein 
levels of paxillin during differentiation and fusion. Paxillin is a 
multi-domain scaffold protein that recruits structural and sig-
naling molecules to focal adhesions where it performs critical 
roles in transducing adhesion and growth factor signals to elicit 
changes in the cytoskeleton and gene expression (  Brown and 
  Someya et al., 2001  ). Furthermore, in   Drosophila  , Loner is 
  believed to modulate the Dock180/Rac1 pathway, leading to 
membrane ruffl  ing and myoblast fusion (  Chen et al., 2003  ). 
We assessed total Rac1 and ARF6 protein levels by Western 
analysis in all cell lines, and found no difference ( Fig. 4, A and D ). 
   To determine if Rac1 and ARF6 activation is affected in Brag2Si, 
Dock180Si, and DKD cells, we performed a Rac-GTP pull-
down assay, using PAK-GST and an ARF6-GTP assay using 
GGA3-GST fusion proteins with lysates from cells at d 3 in 
DM. As shown in   Fig. 4 B  , a dramatic decrease in Rac1-GTP 
levels was observed in the Dock180Si and the DKD cells, but 
not in the Brag2Si cells. The levels of Rac-GTP were quantifi  ed 
with CntSi serving as the normalized control. Dock180Si dis-
played the lowest levels of Rac-GTP (43   ±   14.4 a.u.), followed 
by DKD (61   ±   14.9 a.u.), both of which were signifi  cantly lower 
than the controls CntSi and Cnt2Si, respectively (  Fig. 4 C  ). 
Brag2 defi  ciency caused a marked decrease in the ARF6 activ-
ity levels, which was also observed in the DKD cells (  Fig. 4 E  ). 
Unexpectedly, there was a decrease in ARF6-GTP levels in the 
Dock180-defi  cient cells (73  ±  4.7 a.u.), intermediate when com-
pared with the control and the Brag2Si (42   ±   13.2 a.u.) cells 
(  Fig. 4 F  ). Thus, as in   Drosophila  , Dock180 modulates Rac 
  activation during mammalian myoblast fusion, whereas Brag2 
regulates ARF6 activity. Our results indicate that potential cross-
talk between these two GEFs occurs at the level of ARF6 activa-
tion, which was moderately impeded in Dock180Si cells. 
  Brag2Si myoblasts exhibit defects in 
paxillin localization during differentiation 
  Morphological analysis revealed that although Dock180 was 
dispensable for myotube elongation, loss of Brag2 resulted in a 
failure to elongate. This prompted an analysis of cell adhesion 
molecule expression. Although cellular levels of E-cadherin and 
  Figure 4.       Brag2 and Dock180 deﬁ  ciency  decreases 
GTPase activity.   (A) Western blot analysis of total expression 
of Rac in each cell line after d 3 in DM. Rac migrates as 
a 21-kD protein and GAPDH migrates as 35-kD protein. 
(B) Western blot indicating the level of activated Rac, as 
detected in lysates at d 3 in DM using a pull-down assay 
with GST-fused PAK protein-binding domain. Lysates from 
CntSi cell line were treated with GTP    S and GDP for posi-
tive and negative controls, respectively. (C) The histogram 
represents the levels of GTP-Rac as determined by three 
independent experiments. All samples were normalized to 
total protein and Brag2Si, Dock180Si, Cnt2Si, and DKD 
values are also normalized to the Rac-GTP levels observed 
in CntSi. (D) Western blot analysis of total expression of 
ARF6 after d 3 in DM. ARF6 migrates as a 20-kD protein. 
(E) Western blot indicating the level of activated ARF6, 
as detected in lysates at d 3 in DM using a pull-down as-
say with GST-fused GGA3 protein-binding domain, which 
speciﬁ  cally binds ARF6-GTP. (F) The histogram represents 
the levels of ARF6-GTP as determined by three indepen-
dent experiments. All samples were normalized to total 
protein and Brag2Si, Dock180Si, Cnt2Si, and DKD val-
ues are also normalized to the ARF6-GTP levels observed 
in CntSi at d 3 in DM.     
  Figure 5.       Dock180 deﬁ   ciency in myotubes increases cellular levels of 
      1  -integrin.   (A) Western blot analysis of total protein levels of       1  -integrin at 
d 6 in DM.       1  -integrin migrates as a 130-kD protein and loading control 
GAPDH migrates as 35-kD protein. (B) Western blot analysis of total pro-
tein levels of E-cadherin. E-cadherin migrates as a 120-kD protein; the 90-kD 
band likely reﬂ   ects digestion of the extracellular domain during lysate 
preparation. (C) Western blot analysis of M-cadherin total protein levels. 
M-cadherin migrates as a 130-kD protein.     1011 MOLECULAR BASIS OF CELL–CELL FUSION   •   PAJCINI ET AL.
this observation was due to a disruption in ARF6 or Rac1 local-
ization. Analysis of Rac1 localization during early fusion failed 
to distinguish any differences between the cytoplasmic distribu-
tion of Rac1 in control myotubes, bragballs, or Dock180-defi  cient 
thin myotubes (Fig. S5, available at http://www.jcb.org/cgi/
content/full/jcb.200707191/DC1). We examined the localiza-
tion of endogenous ARF6 and paxillin after d 3 in DM. In the 
CntSi cells, ARF6 and paxillin were diffusely dispersed in the 
cytoplasm of nascent myotubes, but colocalized regularly at the 
leading edges of myocytes, depicted by the arrows in   Fig. 7 A  . 
In contrast, in Brag2Si cells, ARF6 was primarily perinuclear and 
concentrated clusters of paxillin (  Fig. 7 B  , arrowheads) formed 
in several areas of the cytoplasm. These alterations in ARF6 and 
paxillin localization are primarily evident in Brag2Si myocytes 
that have attained the bragball morphology. Similar to our ob-
servations during differentiation, Dock180-defi  cient early myo-
tubes exhibited an intermediate morphology, where clusters of 
paxillin (  Fig. 7 C  , arrowheads) were evident, but less frequent and 
generally smaller. Dock180Si myocytes elongated to comparable 
levels with the CntSi cells and normal ARF6 localization was 
observed throughout the entire length of these elongated cells, 
in several of which colocalization of paxillin and ARF6 was ob-
served (  Fig. 7 C  , arrows).    Thus, our data suggest that appropriate 
localization of paxillin is dependent on the localization of ARF6. 
  Brag2-deﬁ  cient cells exhibit limited 
association between ARF6 and paxillin 
 Our  immunofl  uorescence data suggest that ARF6 colocalizes with 
paxillin; however, in order to verify whether physical association 
Turner, 2004  ). It has been suggested that ARF6 activity may be 
required to establish paxillin localization at focal adhesions 
(  Kondo et al., 2000  ). 
  All cell lines were sparsely seeded for 72 h in DM, and 
then stained for myogenin and paxillin. All myogenin-positive 
cells were analyzed for redistribution of paxillin. The images in 
  Fig. 6 A   show the expression of myogenin and redistribution of 
paxillin in CntSi cells. In contrast, in the Brag2Si line, the cells 
that express myogenin do not acquire elongated myocyte mor-
phology and paxillin in these cells fails to redistribute, remain-
ing diffusely localized. We quantifi  ed the distribution of paxillin 
in myogenin-positive cells. In CntSi and Cnt2Si cells, 76   ±   
9.9% and 75   ±   1.2% of the myogenin-positive cells, respec-
tively, redistributed paxillin, whereas only 22   ±   2.4% of the 
Brag2Si cells and 23   ±   10.6% of DKD cells behaved similarly. 
Concordant with its effect on ARF6 activation, Dock180Si cells 
exhibited an intermediate phenotype with 45   ±   7.7% expressing 
myogenin and redistributing paxillin (  Fig. 6 B  ).    To determine 
if aberrant paxillin expression occurs, we tested expression of 
paxillin by Western blot in lysates from cells after d 5 in DM 
(  Fig. 6 C  ). The results in lanes 2, 3, and 5 indicate that in the case 
of Brag2Si, Dock180Si, and DKD cells there is only a slight 
decrease in the protein levels of paxillin when compared with 
the two controls. 
  Paxillin fails to colocalize with ARF6 in 
early fusion of Brag2-deﬁ  cient myoblasts 
  We tested whether the defects in paxillin localization were re-
tained during early fusion of Brag2Si myoblasts and whether 
  Figure 6.       Brag2-deﬁ  cient myoblasts exhibit aberrant paxillin localization during differentiation.   (A) Representative images of CntSi and Brag2Si myo-
blasts after d 3 in DM depicted in phase contrast and immunoﬂ  uorescence, labeled with Hoechst 33258 (blue), myogenin (red), paxillin (yellow), and 
merged. Bar, 50   μ  m. (B) Paxillin redistribution in myogenin-positive cells, d 3 in DM. At least 1,000 myogenin-positive nuclei were counted for each experi-
mental trial, and the error bars indicate the mean   ±   SE of three independent determinations (*, P   <   0.01). (C) Western blot analysis of paxillin expression 
after d 5 in DM under fusion conditions. Paxillin migrates as a 65-kD protein.     JCB • VOLUME 180 • NUMBER 5 • 2008  1012
phages form MNGCs within 48 h. We analyzed the mRNA ex-
pression of Brag2 and Dock180 in IP-harvested macrophages 
cultured with or without IL-4. Similar levels of Brag2 and 
Dock180 mRNA were expressed before and after addition of 
IL-4 (  Fig. 9  , Ai).    
  Intraperitoneal-harvested macrophages are terminally dif-
ferentiated, precluding the establishment of stable cell lines, 
and limiting the amount of material available for experiments. 
To overcome this problem, we modifi  ed the vREGS backbone by 
adding the MSCVpgkEGFP expression cassette in place of the 
puromycin resistance gene. Into this modifi  ed construct, named 
PVR, we subcloned the same shRNAs used for knockdown of 
Brag2 and Dock180 in myoblasts. After large-scale viral produc-
tion, we infected bone marrow (BM) with virus containing the 
Brag2Si (PVR-Brag2Si-BM) and Dock180Si (PVR-Dock180Si-
BM) as well as PVR control virus (PVR-Cnt-BM), following the 
procedure described in Kalberer et al. (  2000  ). Peripheral blood 
analysis for GFP 
+   hematopoietic reconstitution was performed 
by fl  ow cytometry 4 wk after transplantation of donor BM into 
lethally irradiated mice. Myeloid GFP 
+ CD11b 
+ Gr1 
+  , cells were 
sorted from PVR-Brag2Si-BM and PVR-Dock180Si-BM mice 
as well as PVR-Cnt-BM control mice. Knockdown of Dock180 
was confi  rmed in the sorted PVR-Dock180Si-BM myeloid 
cells (  Fig. 9  , Aii), and knockdown of Brag2 was also verifi  ed 
in the PVR-Brag2Si-BM myeloid cells (Fig. S3, available 
at http://www.jcb.org/cgi/content/full/jcb.200707191/DC1). The 
recipient mice were allowed to recuperate from the peripheral 
bleeding for 2 wk, after which time they were given IP injec-
tions of thioglycollate. Only one out of eight PVR-Brag2Si-BM 
mice survived longer than 6 wk after BM transplantation, and 
the sole survivor demonstrated low bone marrow reconstitu-
tion, not yielding enough GFP 
+   macrophages for a fusion assay. 
In contrast, 12 of 12 PVR-Cnt-BM mice, from three independent 
experimental trials, and 6 of 7 PVR-Dock180Si-BM mice, from 
between the two occurs, we performed paxillin immunoprecipi-
tation (IP) during d 3 in DM (  Fig. 8 A  ). In CntSi lysates, anti-
paxillin immunoprecipitates contained abundant ARF6 protein, 
as well as     1  -integrin as compared with immunoprecipitates 
with IgG. The interaction between paxillin and     1 -integrin,  and 
its importance for the establishment of focal adhesions has 
been previously described (  Brown and Turner, 2004  ). Next, we 
tested whether these paxillin interactions are altered in the GEF 
knockdowns (  Fig. 8 B  ).    Our data indicate that the interaction of 
paxillin with ARF6 and     1  -integrin during myoblast fusion is 
severely disrupted in Brag2Si and to a slightly lesser extent in 
the Dock180Si cells when compared with controls (  Fig. 8 B  , 
lanes 2 and 3). Considering that the majority of ARF6 in Brag2Si 
myotubes is in the GDP-bound state, the lack of interaction be-
tween paxillin and ARF6 correlates with the levels of ARF6-GTP 
as observed in the ARF6 activity assay (  Fig. 4 E  ). Collectively, 
these results support a role for activated ARF6 in the transport 
of paxillin to cellular sites crucial for the maintenance of struc-
tural integrity during myotube formation. 
  Dock180 knockdown impairs macrophage 
fusion and multinucleated giant cell 
formation 
  A fundamental question is whether fusion machinery is con-
served among different cell types. We investigated fusion in the 
hematopoietic lineage, where fusion of macrophages results in the 
formation of osteoclasts and multinucleated giant cells (MNGCs). 
In contrast to muscle, no genetically tractable, in vitro model has 
been described to study macrophage fusion. Thioglycollate-
induced activation of intraperitoneal macrophages is a standard 
source of fusogenic macrophages (  Helming and Gordon, 2007  ). 
While occasional fusion events producing only di- or tri-nucleated 
cells occur in the absence of interleukin-4 (IL-4) (  Fig. 9  , Bi) 
upon culturing with IL-4 (  McInnes and   Rennick, 1988  ), macro-
  Figure 7.       ARF6 and paxillin fail to colocalize during early fusion in Brag2-deﬁ  cient cells.   (A) Representative images of CntSi, (B) Brag2Si, and 
(C) Dock180Si myoblasts after d 3 in DM depicted in phase contrast and immunoﬂ  uorescence, labeled for ARF6 (green), paxillin (red), and merged 
with Hoechst 33258 (blue). Arrowheads point to clusters of paxillin observed in Brag2 and to a lesser extent in Dock180 knockdowns. Arrows point to 
colocalization sites of ARF6 and paxillin in the merged ﬁ  elds. Bar, 50   μ  m.     1013 MOLECULAR BASIS OF CELL–CELL FUSION   •   PAJCINI ET AL.
development of the embryonic musculature in   Drosophila  
(  Erickson et al., 1997  ;   Chen et al., 2003  ). Our data show that the 
functions of Brag2 and Dock180 are evolutionarily conserved 
and involve control of differentiation and cell shape in addition 
to fusion, via different mechanisms directed by their respective 
GTPases. Moreover, this study identifi  es Dock180 as a common 
molecular component that controls cell fusion in different cell 
types, providing the fi  rst evidence of shared fusion machinery. 
  Two assays to quantitate myoblast fusion, one by observa-
tion and the other biochemical, complemented each other by 
permitting the detection of morphological differences and by 
removing observer bias and error, respectively. In light of the 
failure of Brag2- and Dock180-defi  cient myoblasts to fuse to 
existing muscle fi  bers in vivo, the low level of fusion observed 
in vitro leads us to conclude that whereas Brag2 and Dock180 
are required for myotube maturation, early fusion in mamma-
lian myotubes is not dependent on Brag2 or Dock180. However, 
it cannot be ruled out that incomplete knockdown, a ubiquitous 
caveat of RNAi experiments, may have contributed to the low 
level of fusion observed. 
  Whereas Dock180 and Brag2 have not previously been 
linked to muscle cell differentiation aside from fusion, our anal-
ysis of individual cells at early stages of differentiation indi-
cated that myoblasts defi  cient in either Brag2 or Dock180 failed 
to effi  ciently exit the cell cycle. These cells were likewise im-
paired in their ability to induce the transcription factor myo-
genin or the contractile protein MHC. Suppression of myogenin 
promoter activity has been previously observed with dominant-
negative mutants of Rac (  Takano et al., 1998  ). However, the role 
of Rac in myoblast differentiation is complex and remains 
poorly understood, as other recent studies suggest that a drop in 
Rac activity is essential for cell cycle withdrawal (  Heller et al., 
2001  ;   Charrasse et al., 2007  ). This implies that inappropriate 
cycling of cells defi  cient in Dock180 may occur though Rac-
  independent mechanisms, possibly involving interactions of 
Dock180 with Crk and other signaling components involved in 
cell cycle regulation. 
  In further support of Rac independent control of differen-
tiation, Brag2 defi  ciency did not affect Rac activation, yet its 
  effects on cell cycle withdrawal and differentiation were more 
severe when compared with Dock180. Cells defi  cient in both 
two independent trials, survived the reconstitution period and 
were treated with thioglycollate. 
  Despite high levels of reconstitution, some endogenous 
macrophages remained in the intraperitoneal cavity at the time 
of thioglycollate treatment because a combination of GFP 
+   and 
GFP 
      CD11b 
+   cells were sorted from the intraperitoneal lavage 
of both PVR-Dock180Si-BM and PVR-Cnt-BM mice. Both 
GFP 
+   and  GFP 
      macrophage populations from PVR-Dock180Si-
BM mice were seeded for fusion analysis. Knockdown of ex-
pression of Dock180 was confi  rmed in GFP 
+  PVR-Dock180Si-BM 
macrophages seeded for fusion (  Fig. 9  , Aiii). 
  MNGCs formed readily in both control populations of the 
uninfected, endogenous GFP 
      PVR-Dock180Si-BM and in the 
transduced, transplanted GFP 
+   PVR-Cnt-BM cells, but only 
in the presence of IL-4 (  Fig. 9  , Bii and Biii). In the PVR-
Dock180Si-BM macrophages most of the cells did not fuse. 
A few tri-nucleated cells were observed, and formation of MNGCs 
was rare (  Fig. 9  , Biv). After the fi  rst intraperitoneal lavage, sur-
vival surgery was performed and 4 wk later the procedure was 
repeated. In both instances, fusion index was analyzed 4 d after 
the addition of IL-4 and the results are shown in   Fig. 9 C  . As in 
the analysis of myoblast fusion, both tri+ and penta+ nucleated 
cells were counted. PVR-Dock180Si-BM showed a marked 
decrease in fusion, 15   ±   1.6% for tri+ nucleated cells and only 
5.6   ±   1.7% for penta+ nucleated cells, when compared with 
both control populations, the fusion index of which exceeded 
42% under both fusion criteria. 
  Despite contrasting morphological appearances and dis-
tinct cellular functions, there is a similar defect in the fusion of 
myoblasts and macrophages defi  cient in Dock180 (  Fig. 9 D  ). 
Thus, our results indicate that Dock180 contributes to the 
development of fully mature multinucleated cells in different 
models and cell lineages. 
  Discussion 
 Whether the formation of multinucleated cells by fusion evolved 
independently in different cell types or if there exist common 
underlying mechanisms is unknown. In this study we have in-
vestigated the mammalian homologues of   Loner   and   Myoblast 
city,   which have previously been found to be essential in the 
  Figure 8.       Paxillin physical interaction with ARF6 and 
      1  -integrin is disrupted in Brag2 and Dock180-deﬁ  cient 
cells.   (A) Cell lysates of CntSi myoblasts in d 3 DM under 
fusion conditions were immunoprecipitated using anti-
Paxillin antibody and mouse IgG serum as negative control. 
Immunoblotting was performed for ARF6 (20-kD) and 
      1  -integrin (130- and 100-kD). 5% of lysate extract was 
immunoblotted for paxillin (65-kD) and GAPDH (35-kD) 
in order to verify equal amounts of cell lysates. (B) Cell 
lysates of each cell line were immunoprecipitated using 
anti-Paxillin antibody and immunoblotted for presence of 
ARF6 and       1  -integrin. 1% of lysate extract was immuno-
blotted for paxillin and GAPDH in order to verify equal 
amounts of cell lysates.     JCB • VOLUME 180 • NUMBER 5 • 2008  1014
  Figure 9.       Macrophages deﬁ  cient in Dock180 fail to form MNGCs.   (A) (i) Brag2 (1,100 bp) and Dock180 (745 bp) expression in thioglycollate-induced 
IP-harvested macrophages before and after treatment with IL-4 as indicated by RT-PCR analysis.     -actin (300 bp). (ii) Semi-quantitative RT-PCR show-
ing expression of Dock180 in CD11b 
+  Gr1 
+   monocytes obtained from GFP 
+   peripheral blood of PVR-Cnt-BM and PVR-Dock180Si-BM mice 4 wk after 
transplantation. (iii) Semi-quantitative RT-PCR showing expression of Dock180 in CD11b 
+   IP-macrophages of PVR-Cnt-BM and PVR-Dock180Si-BM mice 
6 wk after transplantation under fusion conditions. (B) Phase-contrast and immunoﬂ  uorescence images of IP-harvested macrophages from: (i) PVR-Cnt-BM 
macrophages serving as negative fusion control cultured without IL-4; (ii) GFP 
-   cells from PVR-Dock180Si-BM representing the endogenous macrophage 
population cultured with IL-4; (iii) GFP 
+   cells from PVR-Cnt-BM representing the transplanted control population cultured with IL-4; and (iv) GFP 
+   cells from 
PVR-Dock180Si-BM representing the transplanted Dock180-deﬁ  cient population cultured with IL-4. MNGC formation can be distinguished by the cluster of 1015 MOLECULAR BASIS OF CELL–CELL FUSION   •   PAJCINI ET AL.
phenotype combined with previous results, which indicate that 
overexpression of an ARF6 GAP PAG3 decreases the recruit-
ment of paxillin to focal adhesions (  Kondo et al., 2000  ), led us 
to analyze the localization of paxillin. During differentiation 
and fusion, distribution of paxillin was severely disrupted in 
myogenin-positive Brag2Si and DKD cells. A failure to redis-
tribute paxillin upon differentiation accounts for the adhesion 
defect observed in bragballs, where a newly formed multinucle-
ated cell is incapable of creating or maintaining functional focal 
adhesions, causing collapse into the bragball morphology. 
  Our immunoprecipitation and immunofl  uorescence data 
identify an association between paxillin and ARF6. Further-
more, there is a strong correlation between a defi  ciency in ARF6 
activity and improper localization of paxillin during fusion. The 
intermediate drop in ARF6 activity observed in Dock180Si 
cells, according to our model (  Fig. 10  ), accounts for the moder-
ate paxillin distribution defect observed during differentiation 
and the minor paxillin clustering observed during fusion.    It is 
possible that the observed increase in total     1 -integrin  protein 
levels in Dock180-defi  cient cells combined with normal cell 
motility during differentiation (Video 3) could account for the 
ability of Dock180Si myotubes to elongate. Further analysis 
will determine if other structural components of focal adhesions 
such as vinculin and focal adhesion kinase are specifi  cally 
transported by ARF6 activation after differentiation, and how 
integrin levels affect morphology in Dock180-defi  cient cells. 
  In contrast to skeletal muscle, there is little known about 
the intracellular mechanisms of cell fusion in nonmuscle cell 
types (  Vignery, 2005  ). Knockdown in primary macrophages, 
which are differentiated cells not amenable to passage in cul-
ture, required introduction of shRNA constructs in dividing 
  hematopoietic stem cells (HSCs). In the case of Brag2, an un-
expected role for this molecule in HSC biology was revealed by 
the repeated inability to achieve bone marrow reconstitution us-
ing HSCs infected with the Brag2 shRNA. Further experiments 
Dock180 and Brag2 more closely mimicked the differentiation 
and morphological defects observed in Brag2-defi  cient cells. 
Although ARF6 has not previously been linked to cell cycle, it 
has been recently shown that Brag2 can localize to the nucleus 
(  Dunphy et al., 2007  ), where its functions in cell cycle regula-
tion have not been characterized to date. Their similar effects on 
cell cycle withdrawal and initiation of differentiation suggest 
that Brag2 and Dock180 function in a common pathway possi-
bly through ARF6. 
  The similar defects early in differentiation notwithstand-
ing, disparity between Brag2 and Dock180 are highlighted by 
the striking morphological differences between the two during 
fusion, demonstrating unique roles of each in myotube matura-
tion. Defects in skeletal muscle maturation have been previ-
ously reported in myoferlin null mice, which formed myotubes 
with signifi  cantly reduced myofi  ber cross-sectional area and 
muscle mass ( Doherty et al., 2005 ). Our data indicate that Brag2 
and Dock180 are dispensable for myoblasts proliferation but 
that they play critical roles in the orchestration of skeletal mus-
cle formation, especially in the later stages of myotube growth. 
It is possible that the different morphological observations relate 
to the distinct roles that each GEF carries out in the regulation 
of its respective GTPase. We have shown that Brag2 defi  ciency, 
and to a lesser extent Dock180 defi  ciency, leads to ARF6 in-
activity whereas Dock180 defi  ciency exclusively leads to a drop 
in Rac activity. Furthermore, with respect to Dock180, these results 
are in agreement with recent results in which Trio, another GEF 
with dual specifi  city for Rac and Rho, severely impairs myoblast 
fusion when its levels are decreased by RNAi (  Charrasse et al., 
2007  ). Unlike Trio, Dock180 has no cross-specifi  city for Rho, 
thus it may be the combination of both Rac and Rho inactiva-
tion, which results in the severe fusion defect of Trio defi  ciency. 
Time-lapse analysis showed that in contrast to the Dock180-
 defi  cient cells, absence of Brag2 rendered nascent myotubes 
unable to extend and adhere to the surface. This unique Brag2 
  Figure 10.       Model for the roles of Brag2 and Dock180 in 
cell  –  cell fusion.   Upon receipt of signals from fusion recep-
tors on the cell surface Brag2 activates ARF6, which in turn 
transports paxillin to sites of focal adhesion, where it com-
plexes with integrins thereby maintaining the structural integ-
rity required during myotube maturation. Dock180 regulates 
Rac-GTP activity thus primarily contributing to lamellipodia 
formation and cytoskeletal rearrangement. Dock180 can ac-
tivate ARF6, thus in part functioning in paxillin transport and 
possibly integrin recycling.     
nuclei with a large surrounding area of cytoplasm, the extent of which is indicated by dashed lines. (C) Fusion index analysis in macrophages from each 
of the four populations shown in B. Two multinucleated categories are analyzed and a minimum of 1,000 nuclei were counted for each fusion assay. Error 
bars indicate the mean   ±   SE of four independent fusion assays. P values were determined by   t   test between the two positive fusion controls and the PVR-
Dock180Si-BM macrophages (*, P   <   0.03; **, P   <   0.0005). (D) Comparison of fusion indexes, of three or more nuclei, in myoblasts and macrophages 
deﬁ  cient in Dock180. Error bars indicate the mean   ±   SE of four independent fusion assays (*, P   <   0.00001; **, P   <   0.0005).     
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Dock180: GTGAATGAGGTACAGCGATTCG mouse cDNA sequences. 
As infection and shRNA control (CntSi), REGS-GFP-489 described in   Sen 
et al. (2004  ) was used. Three separate stable cell lines were generated on 
C2C12 cells for each of the selected shRNAs. For Brag2+Dock180 DKD 
generation, cells veriﬁ  ed in knockdown of Brag2 expression were infected 
two extra rounds with virus expressing the Dock180 shRNA. As DKD con-
trol, the CntSi stable cell line was infected two extra rounds with the control 
REGS-GFP-489 shRNA. 
  Semi-quantitative and quantitative RT-PCR 
  RNA was harvested from stable cell lines in GM or DM d 4 by RNeasy 
mini kit (QIAGEN) and 500 ng of total RNA was used in semi-quantita-
tive RT-PCR analysis with Superscript III One-Step RT-PCR (Invitrogen) for 
Brag2 (5    : GTCACATGCAGCACAGTCCCCCTTCCTT; 3    : AGCTTCCG-
GCAGTCCTTCTCCCTCTACG) and Dock180 (5    :TCATCATGGAGAC-
GCTGCTT; 3    : TCGTCTCCTCTGCCTCCTTC). The RT-PCR conditions for 
each analysis were as described in manufacturer  ’  s instructions, with an-
nealing temperatures of 63  °  C for 30 s. For RT-PCR controls, 50 ng of total 
RNA were used, with primers for GAPDH (5    : CACTGAGCATCTCCCT-
CACA; 3    : TGGGTGCAGCGAACTTTATT) and     -actin (5    : TTTGAGA-
CCTTCAACACCCCAGCC; 3    : AATGTCACGCACGATTTCCCGC) with 
annealing temperatures of 55  °  C for 30 s. For Brag2 and Dock180 26, 
28, and 30 cycles were tested, for GAPDH and     -actin 19, 21, and 23 
cycles were tested. Semi-quantitative RT-PCR of CD11b 
+   and Gr1 
+   cells 
FACS sorted from peripheral blood was performed as described above 
except that 50 ng of total RNA used, while in the RT-PCR of harvested IP 
macrophages 200 ng of total RNA was used. Numbers of cycles ana-
lyzed for each experiment was 37, 39, and 41. For qRT-PCR 1   μ  g of 
total RNA from GM or DM d 4 stable cell lines was used to synthesize 
single-stranded cDNA using ﬁ  rst Strand cDNA Synthesis kit (Roche). 1   μ  l 
of the cDNA synthesis reaction mix was used with Platinum SYBR Green kit 
from Invitrogen in the real-time thermocycler from Corbett Research Rotor-
Gene RG3000 for quantitative analysis of mRNA gene expression. New 
primers were designed for Brag2 (5    : CTCCAGCCTCAAAAAGGAGTC; 
3    : CTAGGCTTAGGAGCACAGCACT) and Dock180 (5    : TTAAGAACCT-
CATCGGGAAGAA; 3    : TCCAGAAATCTCTTGTTCAGCA) speciﬁ  cally for 
real-time analysis. 
  Immunoﬂ  uorescence 
  Stable cell lines were seeded for fusion or differentiation analysis in tripli-
cate. Cells seeded for fusion as described above were ﬁ  xed every day for 
6 d with 1.5% paraformaldehyde 15 min at room temperature (RT), per-
meabilized with 0.3% Triton 10 min at RT, and blocked with 20% FBS for 
30 min at RT. For differentiation analysis, cells were seeded 2.0   ×   10 
4   in 
6-cm collagen-coated plates and treated as described above after 72 h in 
DM. Primary antibodies for MHC (Chemicon) diluted 1:50 in blocking buf-
fer, incubated at RT for 30 min; secondary Alexa-488 Gt    Ms 1:1,000 
(Invitrogen). Primary antibodies for myogenin (Santa Cruz Biotechnology, 
Inc.) diluted 1:100, incubated at RT for 1 h; secondary Alexa-546 Gt    Rb 
1:1,000. Primary antibodies for paxillin (BD or Santa Cruz Biotechnology, 
Inc.) diluted 1:100, incubated at RT for 1 h; secondary Alexa-488 Gt    Ms 
1:1,000 or Alexa-647 Gt    Rb 1:1,000. Primary antibodies for Rac (Up-
state Biotechnology) 1:50 and ARF6 (AbCam) 1:50 incubated at RT for 
1 h secondary Alexa-488 Gt    Ms 1:1,000. Nuclear staining of cells with 
Hoechst 33258 (Sigma-Aldrich) diluted 1:10,000 and incubated at RT for 
15 min. Cells were imaged with Carl Zeiss Axioplan2 using 40x water im-
mersion objective, or Carl Zeiss Axiovert 200M using NeoFluar 10 or 20x 
objectives and an ORCA-ER C4742-95 (Hamamatsu Photonics) digital 
camera. Openlab 4.0.2 and Volocity 3.6.1 (Improvision) were the soft-
ware used for image acquisition. Images were composed and edited in 
Openlab 4.0.2 or Photoshop 7.0 (Adobe). Background was reduced using 
contrast adjustments and color balance was performed to enhance colors. 
All modiﬁ  cations were applied to the whole image. 
      -Gal complementation fusion analysis 
  C2C12 control cells and stable cell lines Brag2Si and Dock180Si were 
split and each fraction was retrovirally infected with virus containing con-
structs expressing either the     -gal fragment     -GFP on the MFG vector back-
bone or     -GFP on the pwz1 vector backbone modiﬁ  ed to include GFP as 
a fusion to the C terminus of the     -fragment. All infected cells were cell 
sorted by ﬂ  ow cytometry (DIVA-Van, Becton Dickinson) for GFP expression. 
Before seeding for fusion analysis, the     -GFP and     -GFP Brag2Si cells 
were trypsinized and mixed in equal proportions and seeded in 96-well 
plates, 10,000 per well, 24 wells total. Five plates were seeded for fusion 
in this manner and analysis of     -gal activity was measured as described 
(  Wehrman et al., 2005  ) daily for a total of 5 d using GAL-screen substrate 
will determine the function of Brag2 in HSC homing, but   defects 
in adhesion and niche recognition are two potential explana-
tions. Generation of shRNA-expressing intraperitoneal macro-
phages was possible in the case of Dock180. Defi  ciency in 
Dock180 prevented the formation of MNGCs and the rare fu-
sion events that did occur resulted in cells that had low nuclear 
number, and aberrant morphology that lacked the characteristic 
centrally located nuclear cluster common in the control MNGCs. 
From our data, it is apparent that the loss of Dock180 leads to a 
signifi  cant fusion defect in both myoblasts and macrophages. 
These fi  ndings are the fi  rst to identify a role for a single mole-
cule in fusion in different lineages, and the results suggest that 
muscle and macrophages use redundant intracellular machinery 
during the fusion process. 
  It is becoming apparent that the dynamic morphological 
state of a cell refl  ects the particular balance of GEFs present at 
a given time. For example, a recent study (  Yeh et al., 2007  ) 
found that the introduction of single, engineered GEFs and their 
domains could induce morphological changes including the for-
mation of fi  lopodia or lamellipodia. This study and others (  Lee 
et al., 2001  ;   Dunphy et al., 2006  ;   Francis et al., 2006  ;   Otani et al., 
2006  ;   Charrasse et al., 2007  ) suggest that cell morphology is sub-
ject to manipulation by the repression or expression of particular 
GEF activities. We show that GEFs control the differentiation-
specifi  c morphology of skeletal muscle cells and MNGCs. 
The effects of individual GEFs are unique, an example being 
the markedly different impact of Dock180 and Brag2 on muscle 
morphology. In addition, their functions are cell type specifi  c as 
indicated by analyses of a variety of nonfusion-related func-
tions of Dock180 and Brag2 in mammalian cells (  Hasegawa 
et al., 1996  ;   Dunphy et al., 2006  ;   Hiroi et al., 2006  ;   Handa et al., 
2007  ). Conversely, our experiments demonstrate that there 
are fundamental GEF-controlled fusion processes that are 
  conserved across lineages, underscored by the similar role of 
Dock180 in fusion of different cell types. This paper furthers 
our understanding of the generation of multinucleated cells and 
the GEF-mediated intracellular functions responsible for their 
formation and maintenance. 
  Materials and methods 
  Cell culture 
  C2C12 mouse myoblasts were cultured at 10% CO  2   37  °  C in DMEM sup-
plemented with 20% FBS (GM). Myoblasts were differentiated for fusion 
under low mitogenic conditions in DMEM supplemented with 2% ES, (DM) 
on collagen (Sigma-Aldrich) coated plates, under the following seeding 
densities: 6-cm plate, 5   ×   10 
5   cells; 10-cm plate, 1.5   ×   10 
6   cells; 15-cm 
plate, 3.7   ×   10 
6   cells. DM was replaced every 24 h for a total of 7 d. 
Where indicated, ArabinoseC (10 
    5   M) was added to DM at d 2 and/or 
d 3 during differentiation. 
  shRNA stable cell line generation 
  shRNAs to knockdown Dock180 and Brag2 expression were generated 
using the REGS method and inserted into vREGS expression vector as de-
scribed (  Sen et al., 2004  ). Ecotropic phoenix cells were transfected using 
FuGENE 6 (Roche) with vREGS constructs. C2C12 cells were infected with 
viral supernatants containing polybrene (5   μ  g/ml 
    1  ) and centrifuged for 
30 min at 2,000   g  . Cells were infected two rounds and selected on puro-
mycin (1   μ  g/ml 
    1  ) 48 h after last infection. After veriﬁ  cation of knockdown 
by RT-PCR and DM morphology analysis, the following shRNA-REGS con-
structs were selected for each gene. Listed are the shRNA nucleotides 
that correspond to the Brag2: GGAGTTGCCGCCTGACCGTGGGT and 1017 MOLECULAR BASIS OF CELL–CELL FUSION   •   PAJCINI ET AL.
membranes (Amersham). Membranes were then incubated with antibodies 
against Rac1 (1:250; Cytoskeleton, Inc.), AFR6 (1:500; Abcam), Paxillin 
(1:5,000; BD Transduction Laboratories),       1  -integrin (1:80; R  &  D Systems), 
E-cadherin (1:200; Santa Cruz Biotechnology, Inc.), M-cadherin (1:1,000; 
BD Transduction Laboratories), and GAPDH (1:10,000; Santa Cruz Bio-
technology, Inc.). Membranes were then incubated with HRP-conjugated 
secondary antibodies (1:5,000; Zymed Laboratories) and detected by ECL 
or ECL 
+   detection reagents (Amersham). 
  Immunoprecipitation 
  Cell lysates from d 3 DM of each of the ﬁ  ve stable cell lines were prepared 
as described above, in addition they were pre-cleared with 30   μ  l of pro-
tein-G agarose (Calbiochem). 2 mg of pre-cleared lysate was incubated 
with 2   μ  g of anti-paxillin antibody or mouse IGg serum overnight at 4  °  C 
with agitation, followed by incubation at 4  °  C with agitation with 30   μ  l of 
protein-G agarose for 2 h. Precipitates were washed for four rounds in lysis 
buffer supplemented with increasing concentrations of NaCl (150  –  300 mM). 
Immunoprecipitates were pelleted by centrifugation and resuspended in 
15   μ  l of Laemmli buffer (Sigma-Aldrich); immunoblotting was performed as 
described above. 
  Time lapse 
  Controls and Brag2Si, Dock180Si, and DKD C2C12 stable cell lines were 
seeded for fusion 5.0   ×   10 
4   cells/well in 24-well collagen-coated plates. 
ArabinoseC (Sigma-Aldrich) was added to the cells d 2 and d 3 after the 
transition to DM media. Cells were imaged using Zeiss Axiovert 200M 
equipped with time-lapse apparatus CTI-Controller 3700 Digital; Tempcon-
trol 37  –  2 digital; scanning stage Incubator XL 100/135 (PECON). Frames 
were captured every 15 min for a total of 60 h, encompassing d 2, 3, and 
4 during myoblast differentiation and fusion. Images were acquired and 
analyzed using Volocity 3.6.1 (Improvision). 
  Immunocytochemistry 
  1 wk after injection, TA muscles were dissected and immersed in PBS/0.5% 
EM-grade PFA (Polysciences) for 2 h at RT followed by overnight immersion 
in PBS with 20% sucrose at 4  °  C. Fixed tissue was embedded in optimal 
cutting temperature compound (Tissue-Tek; Sakura Finetek), snap-frozen in 
isobutene and liquid nitrogen, and sectioned at 10   μ  m thickness. Tissue 
sections were blocked in PBS/20% normal goat serum/0.3% Triton X-100 
(blocking buffer); incubated with primary antibodies (diluted in blocking 
buffer; 2   μ  g/ml rabbit anti-GFP (Invitrogen), 3   μ  g/ml rat anti-laminin-2 (Upstate 
Biotechnology), and incubated with 10   μ  g/ml of the secondary-conjugated 
antibodies anti  –  rabbit-Alexa488 and anti  –  rat-Alexa546 (Invitrogen). 
Sections were then washed overnight and mounted with Fluoromount G. 
Images of muscle transverse sections were acquired using an epiﬂ  uorescent 
microscope (Axioplan2; Carl Zeiss), Fluar 20x/0.75 objective lenses, and 
a digital camera (ORCA-ER C4742-95; Hamamatsu Photonics). The soft-
ware used for acquisition was OpenLab 4.0.2 (Improvision). All images 
were composed and edited in Photoshop 7.0 (Adobe). Background was 
reduced using brightness and contrast adjustments, and color balance was 
performed to enhance colors. All the modiﬁ  cations were applied to the 
whole image using Photoshop 7.0 (Adobe). 
  Online supplemental material 
  Several ﬁ  gures and videos throughout this article are marked as supple-
mentary. This material is available online and includes ﬁ  gures depicting 
the depletion of Brag2 and Dock180 protein levels, analysis of the mor-
phology and BrdU incorporation for each stable cell line during active 
growth in myoblast conditions, as well as analysis of the fusion potential of 
Brag2- and Dock180-deﬁ  cient myoblasts in vivo  ,   when injected in the TA 
of immunodeﬁ  cient mice. Furthermore, time-lapse visualization of each sta-
ble cell line during d 2, 3, and 4 while in DM conditions is also available 
online. All online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200707191/DC1. 
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reagents (Applied Biosystems). Luminescence was measured in a Tropix 
TR717 luminometer. The exact process was performed for the C2C12 con-
trol and Dock180Si cells coinciding with the Brag2Si analysis described 
above. Background luminescence reading was measured each day with 
C2C12 control cells seeded 10,000 per well 6 h before sample analysis. 
  Bone marrow MSCV transduction and transplantation 
  Retroviral vector design for BM transductions was based on the vREGS 
backbone, in which the puromycin resistance gene was replaced by 
MSCVpgkEGFP via digestion by AgeI and ClaI (pVR-GFP). The siRNAs 
veriﬁ   ed for successful knockdown of Brag2 and Dock180 in myoblasts 
were inserted into cloning site of pVR-GFP. Large-scale retrovirus produc-
tion was performed 24 h after double-transfection of each construct + pCL-
eco into 293T cells. Bone marrow transduction was performed as described 
(  Kalberer et al., 2000  ). In brief, 6- to 8-wk-old mice (C57BL/6) mice were 
used as donor (male) and recipients (female). Donor mice were injected 
with 15 mg/ml of 5-ﬂ  uorouracil (Sicor) per 10 g of mouse weight. Har-
vested BM cells were prestimulated for 24 h in IL6, IL3, and SCF cytokine 
cocktail (Peprotech), then infected for two rounds with MSCV retrovirus on 
RetroNectin (10   μ  g/ml) (Takara) coated plates in the presence of 5   μ  g 
protamine sulfate (Sigma-Aldrich). Transduced BM cells were isolated by 
sorting for GFP expression (DIVA-Van, Becton Dickinson) 24 h after last in-
fection, and 50,000  –  200,000 cells were IV injected into lethally irradi-
ated recipient mice, a total of 18 Gy of whole-body irradiation administered 
in split dosage. 4 wk after transplantations, recipient mice were inspected 
for hematopoietic reconstitution by ﬂ   ow cytometry of GFP 
+   peripheral 
blood (PB) followed by analysis of the presence of myeloid (Gr1, CD11b) 
and lymphoid (B220, CD3) lineage markers (BD PharMingen). Cells in the 
myeloid compartment of GFP 
+   PB were sorted and RNA was harvested for 
RT-PCR analysis. 
  IP macrophage harvest and fusion assay 
  Recipient mice conﬁ  rmed for GFP 
+   PB reconstitution were harvested for res-
ident macrophages as described (  Helming and Gordon, 2007  ). In brief, 
recipient mice were IP injected with 1 mL of sterilized Thioglycollate me-
dium brewer modiﬁ  ed (BD). IP lavage was performed 4 d after injections 
with ice-cold PBS. Harvested cells were sorted for GFP expression, and 5.0   ×   
10 
5   cells were seeded for fusion analysis on Permanox-coated SonicSeal 
slide wells (Nalge Nunc). Seeded cells were cultured in Opti-MEM (GIBCO 
BRL) supplemented with 10% FBS, and to induce MNGC formation 5 ng/ml 
of IL-4 (Peprotech) was added to the media. Cells were analyzed for fusion 
after culturing for 96 h. After the lavage, survival surgery was performed 
with a success rate of 100%, and 3-4 wk after initial procedure, recipient 
mice were reinjected with thioglycollate and a second IP lavage and fusion 
analysis was performed. 
  BrdU analysis 
  BrdU labeling and detection kit (Roche) was used on controls and Brag2Si, 
Dock180Si and DKD C2C12 stable cell lines, which were seeded 10,000 
cells/6 cm on collagen coated plates for differentiation analysis. After 24 h 
in DM, BrdU labeling reagent was added to the cells with fresh DM media 
for an additional 6 h, after which the cells were ﬁ  xed and detected for 
  immunoﬂ  uorescence as per manufacturer  ’  s instructions. Following BrdU 
detection procedure, cell nuclei were labeled with To-Pro (invitrogen) in PBS. 
Cells were imaged using laser-scanning confocal microscope (LSM510 
Axiovert 200M; Carl Zeiss) using NeoFluar 10x objective lenses and maxi-
mum optical section with the LSM software. After acquisition, images were 
composed and edited in Photoshop 7.0 as described above. 
  GTP activity assays and immunoblotting 
  Rac-activity assay was essentially performed as per manufacturer  ’  s instruc-
tions of Rac Activation Assay (Cytoskeleton, Inc.). In brief, controls and 
Brag2Si, Dock180Si, and DKD C2C12 stable cell lines were seeded for 
fusion analysis in 15-cm collagen-coated plates. After d 3 in DM, cells 
were lysed at room temperature in 50 mM Tris, pH 7.5, 10 mM MgCl  2  , 
0.3 M NaCl, and 2% IGEPAL. Lysates were cleared by centrifugation for 
5 min at 6,000 rpm at 4  °  C, and protein quantiﬁ  cation was determined by 
Bradford assay (Bio-Rad). 5 mg of each protein lysate was incubated with 
GST-PAK PBD protein beads (25   μ  g) for 1 h at 4  °  C with agitation. PAK PBD 
beads were pelleted by centrifugation and resuspended in 15   μ  l of Laem-
mli buffer (Sigma-Aldrich). ARF6 activity assay was performed similarly but 
using GST-GGA3 PBD beads for incubation with the d 3 DM lysates of 
each of the ﬁ  ve stable cell lines. Western blot analysis for Rac and ARF6 
activity and other protein samples was conducted using NuPage system 
from invitrogen. Samples were loaded in 10% Bis-Tris precast gel, resolved by 
running with MES or MOPS SDS buffer, and transferred onto Immobilon-P JCB • VOLUME 180 • NUMBER 5 • 2008  1018
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